Dow Up 0.91% Nasdaq Up 0.81%

Becton, Dickinson and Company (BDX)

-NYSE
179.73 Up 3.29(1.86%) Sep 30, 4:02PM EDT
|After Hours : 179.73 0.00 (0.00%) Sep 30, 5:12PM EDT
Prev Close:176.44
Open:177.02
Bid:160.99 x 100
Ask:180.34 x 300
1y Target Est:183.04
Beta:0.975248
Earnings Date:Nov 2 - Nov 7 (Est.)
Day's Range:177.02 - 180.57
52wk Range:129.50 - 181.76
Volume:1,156,117
Avg Vol (3m):792,938
Market Cap:38.27B
P/E (ttm):34.30
EPS (ttm):5.24
Div & Yield:2.64 (1.48%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for BDX

Comparison

Symbol% ChgMkt Cap
BDXUp 1.86%38.27B
BAXUp 1.45%25.89B
ABTUp 2.05%62.17B

Key Statistics

Forward P/E (1 yr):19.00
P/S (ttm):3.05
Ex-Dividend Date:07-Sep-16

Analysts

Annual EPS Est (Sep-16) :8.56
Quarterly EPS Est (Sep-16) :2.09
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):1.54

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Becton, Dickinson and Company develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. The company’s BD Medical segment offers syringes and pen needles for diabetes; needles, syringes, and intravenous cat... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback